AVE 0.00% 0.3¢ avecho biotechnology limited

KC love the last paragraph of your post:-POH certainly...

  1. 72 Posts.
    KC love the last paragraph of your post:-

    POH certainly understand this key advantage and the unique opportunity its delivery platform offers in addressing drug abuse- and they are certainly making prospective commercial partners aware of this feature.

    Perhaps in future POH will put more meat into its announcements with some market numbers as King Pharma has done and advise whether or not it has completed the basic elements of an anti abuse management plan which will be required for any future FDA compliance.

    Also agree with you that oral is antiquated. Not questioning the POH science just questioning the marketing of the POH science to perhaps a not-so- biotech sophisticated Australian Institutional market.


 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
55 89268918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59834650 19
View Market Depth
Last trade - 16.12pm 29/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.